Our team was glad to join others across the Flagship Pioneering ecosystem to celebrate International Day of Women and Girls in Science. At the event, our co-founder and CEO Lovisa Afzelius led a panel of distinguished women to discuss company creation. #FlagshipFounded #BiggerLeaps

In our latest employee spotlight meet senior engineer Caroline Wilkinson and learn about her unique role and what inspired her to join Apriori. #AprioriLife #WeAreHiring #JoinUs

We're excited to see that Flagship Pioneering was honored as one of the most innovative companies by Fast Company for the third year in a row! We’re proud to be #FlagshipFounded as we work to create a world that is protected against viral threats. #FCMostInnovative

Apriori Advisor Dr. Jesse Bloom recently spoke to the The New York Times about the research underway at Bloom Lab to understand how coronavirus behaves and continues to evolve. Read the full article: nytimes.com/2024/03/22/hea…

Congrats to our co-founder and CEO Lovisa Afzelius for being named to Inc.'s #FemaleFounders 250 List! Such a well-deserved recognition.

Together with Flagship Pioneering, we convened leading scientists, regulators, and policymakers for a discussion on the future of variant-resilient vaccines and how we are working to get ahead of constantly evolving viruses. Thank you to everyone who made the event a success!

We recently spoke with senior scientist Nicole Thadani, PhD, about her interest in immunology and how her work is motivated by her goal to make a positive difference in the world. #AprioriLife #WeAreHiring #JoinUs

Thanks to CEPI for recognizing the role our Octavia™ platform can play in preparing for and responding to viral outbreaks. Learn how this funding will help us advance our platform and our mission to protect humanity against future viral threats: aprioribio.com/news/apriori-r…

Today is an exciting day to be #FlagshipFounded as Flagship Pioneering announces a new $3.6 billion fund to further transform human health. For our part, we look forward to continuing our work to protect humanity against future viral threats.

Thank you to our CEO Lovisa Afzelius for bringing us together for a picnic to celebrate summer and all of our milestones this year. It was fun to connect with our colleagues outside of the office!

Proactively protecting health is key and we are excited to work with Raj Panjabi M.D. as he joins Flagship Pioneering to lead the Preemptive Health and Medicine Initiative. His deep experience will help us develop variant-resilient vaccines to protect humanity against viral threats.

A new article from Eliza Slawther in Citeline’s In Vivo highlights how Apriori is leading the way in the development of variant-resilient vaccines. Read more about how we are leveraging AI and ML to get ahead of future viral outbreaks: invivo.citeline.com/IV154722/Could…

Thrilled to welcome Seth Berkley, Arup Chakraborty, and Ashish K. Jha, MD, MPH to our Board. Their guidance will be instrumental in helping us advance our mission to protect humanity against viral threats. Read more: aprioribio.com/news/apriori-b… #FlagshipFounded

Our President Craig Williams joined other global healthcare leaders to discuss pandemic preparedness & the importance of data to improve global health outcomes during #SSUNGA79. Thanks to Airfinity for organizing and including us in this important conversation. #FlagshipFounded

Excited to welcome Harry Kleanthous, PhD, as our Chief Scientific Officer. His extensive experience in vaccine R&D will help drive our technologies and our team forward. Read more: aprioribio.com/news/apriori-b… #FlagshipFounded

Meet Max Winston, PhD, director of data science at Apriori! We had the opportunity to talk to him about his work leading our team of data scientists who are advancing our Octavia™ platform. #AprioriLife #WeAreHiring #JoinUs

We are thrilled to announce Craig Williams as CEO of Apriori. Since joining as President last year, Craig has been instrumental in driving operations, building out an early pipeline, and securing key sources of funding and collaboration. aprioribio.com/news/flagship-… #FlagshipFounded

Apriori CEO Craig Williams shared updates about our Octavia platform and pipeline of variant-resilient vaccines, and discussed our growing team at the #FlagshipStudio #JPM25. Hear how we’re reimagining vaccinology to protect against threats: flagshippioneering.com/stories/2025-c…

Meet Katelyn Faircloth, an associate scientist on our team. Read our full Q&A to learn more about Katelyn’s career in vaccine research and her work at Apriori. #AprioriLife

We are excited to announce a research collaboration with The Francis Crick Institute to enhance our capacity to accurately predict viral evolution and develop innovative, prospective vaccine candidates against current and emerging viral threats. Read more here: aprioribio.com/news/Apriori-b…